YD

YD Bio Limited Ordinary Shares

YDES · Nasdaq

YD Bio Limited Ordinary Shares (YDES) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for YD Bio Limited Ordinary Shares in 2026.

Earnings calendar

Next earnings date

Not scheduled

EPS estimate

Revenue estimate

Past earnings

No earnings history available.

Dividend calendar

No dividend history available.

Company profile

Breeze Holdings Acquisition Corp. operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need. The company is based in Taipei, Taiwan.

Sector
Healthcare
Industry
Biotechnology
Country
Taiwan
Exchange
Nasdaq
CEO
Ethan Shen
Employees
4
IPO date
29 Aug 2025
ISIN
KYG983011076
Website
ydesgroup.com

Frequently asked questions

Where is YD Bio Limited Ordinary Shares stock listed?

YD Bio Limited Ordinary Shares (YDES) is listed on Nasdaq.